Kestine 20

Ebastine, the active ingredient in Kestine 20, is a second‑generation H1 antihistamine presented as an oral tablet for oral use. It is employed to relieve symptoms of allergic rhinitis and chronic urticaria in adults and adolescents, reducing histamine‑mediated nasal congestion, sneezing, itching and skin hives without significant sedation.

GNH USA supplies Kestine 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards and is manufactured under strict Good Manufacturing Practice guidelines.

Ebastine acts on allergic pathways to control histamine‑driven conditions.

Allergic rhinitis: alleviates nasal congestion, sneezing, itching and watery discharge. Chronic idiopathic urticaria: reduces the frequency and severity of hives and itching. Seasonal allergic conjunctivitis: helps control eye itching and redness associated with pollen exposure.

Adverse reactions may occur with any antihistamine therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Dry mouth: transient sensation of oral dryness. - Drowsiness: occasional mild sedation. - Nausea: occasional gastrointestinal upset. - Dizziness: brief episodes of light‑headedness.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm reported in rare cases. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: acute, potentially life‑threatening allergic response. - Hepatotoxicity: abnormal liver function tests. - Blood dyscrasias: rare hematologic abnormalities.

Before initiating therapy, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: weigh potential benefits against possible infant exposure. Elderly patients: monitor for increased sedation and adjust dose if needed. Renal or hepatic impairment: use with caution and consider dose modification. Drug interactions: review all concomitant medications for possible interactions. Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ebastine may interact with several drug classes; monitoring is advised.

Major Interactions (Avoid): - Ketoconazole: may increase ebastine plasma concentrations. - Erythromycin: can elevate systemic exposure. - Ritonavir: potent CYP3A4 inhibition may raise ebastine levels.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive sedative effect may occur. - Alcohol: may enhance drowsiness. - Other antihistamines: combined use can increase anticholinergic burden.